Molecular and cytogenetic analysis in stillbirth: results from 481 consecutive cases.

Fetal Diagn Ther

Department of Molecular Medicine and Surgery and Center for Molecular Medicine, Karolinska Institutet, CMM L8:02, Karolinska University Hospital, Stockholm, Sweden.

Published: August 2015

Introduction: The underlying causes of stillbirth are heterogeneous and in many cases unexplained. Our aim was to conclude clinical results from karyotype and quantitative fluorescence-polymerase chain reaction (QF-PCR) analysis of all stillbirths occurring in Stockholm County between 2008 and 2012. By screening a subset of cases, we aimed to study the possible benefits of chromosomal microarray (CMA) in the analysis of the etiology of stillbirth.

Methods: During 2008-2012, 481 stillbirths in Stockholm County were investigated according to a clinical protocol including karyotype or QF-PCR analysis. CMA screening was performed on a subset of 90 cases, corresponding to all stillbirths from 2010 without a genetic diagnosis.

Results: Chromosomal aberrations were detected by karyotype or QF-PCR analysis in 7.5% of the stillbirths. CMA analysis additionally identified two known syndromes, one aberration disrupting a known disease gene, and 26 variants of unknown significance. Furthermore, CMA had a significantly higher success rate than karyotyping (100 vs. 80%, p < 0.001).

Discussion: In the analysis of stillbirth, conventional karyotyping is prone to failure, and QF-PCR is a useful complement. We show that CMA has a higher success rate and aberration detection frequency than these methods, and conclude that CMA is a valuable tool for identification of chromosomal aberrations in stillbirth.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000361017DOI Listing

Publication Analysis

Top Keywords

qf-pcr analysis
12
analysis stillbirth
8
stockholm county
8
subset cases
8
cma analysis
8
karyotype qf-pcr
8
chromosomal aberrations
8
cma higher
8
higher success
8
success rate
8

Similar Publications

Article Synopsis
  • A 36-year-old woman underwent amniocentesis during her pregnancy due to her age, revealing mosaic trisomy 21 with varying levels of affected cells.
  • Despite the genetic abnormality, she was advised to continue with the pregnancy and delivered a healthy baby at 37 weeks.
  • Follow-up tests showed that the baby exhibited low-level mosaicism for trisomy 21 but was normal in phenotype and development at 2 months old.
View Article and Find Full Text PDF
Article Synopsis
  • - A 30-year-old woman underwent prenatal ultrasound at 14 weeks and was found to be carrying a fetus with multiple congenital anomalies, prompting chromosome microarray analysis (CMA) after the pregnancy was terminated.
  • - The analysis revealed a significant deletion on chromosome 5 (5q14.3-q31.1), affecting numerous genes, including NR2F1 and MEF2C, indicating a genetic basis for the fetal conditions observed.
  • - CMA proves to be an effective tool in identifying genetic abnormalities in fetuses with unexplained congenital anomalies, highlighting its value in prenatal genetic testing.
View Article and Find Full Text PDF

Prenatal genetic investigation in pregnancies with oligohydramnios: Results from a single referral medical center.

Taiwan J Obstet Gynecol

November 2024

Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China. Electronic address:

Objective: The aim of this study was to investigate the value of genetic testing using exome sequencing (ES) in oligohydramnios pregnancies with or without other structural abnormalities.

Materials And Methods: A total of 110 singleton pregnancies complicated by oligohydramnios were enrolled, including 52 of isolated oligohydramnios and 58 of non-isolated oligohydramnios. All fetal samples were first tested by quantitative fluorescent polymerase chain reaction (QF-PCR) and followed by chromosomal microarray analysis (CMA).

View Article and Find Full Text PDF
Article Synopsis
  • - The first trimester is critical for organ development but has a high risk of complications, with early pregnancy loss being the most common issue, often indicated by anomalies in the yolk sac.
  • - A case report about a 38-year-old woman with recurrent pregnancy loss revealed an enlarged yolk sac (>10 mm) and confirmed Trisomy 22 through chromosomal microarray analysis.
  • - Early detection using sonography and genetic testing is essential in managing recurrent pregnancy loss, informing pre-conception counseling, and improving future pregnancy outcomes through thorough evaluations of yolk sac size.
View Article and Find Full Text PDF

Objective: To determine the frequency of chromosomal aberrations in chorions after a miscarriage. The second was to examine selected euploid chorions using a next-generation sequencing (NGS) panel designed to assess 43 genes associated with pregnancy loss.

Materials And Methods: The 1244 chorions were tested by targeted quantitative fluorescent PCR (QF-PCR, 827 chorions) and microarray-based comparative genomic hybridization (aCGH, 417 chorions).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!